Durvalumab (D) +/- Tremelimumab (T) plus Platinum Etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of Patients with Long-term Survival in the CASPIAN Study

Reinmuth N., Goldman J. W., Garassino M. C., Chen Y., Hotta K., Hochmair M. J., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.45, no.SUPPL 2, pp.101-102, 2022 (SCI-Expanded)

  • Publication Type: Article / Abstract
  • Volume: 45 Issue: SUPPL 2
  • Publication Date: 2022
  • Journal Name: ONCOLOGY RESEARCH AND TREATMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.101-102
  • Istanbul University Affiliated: No